跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 73 条关于
“SKB105”
全部
73
临床试验
56
药物
6
机构
0
资讯
11
9个月前
Kelun-Biotech and Crescent Biopharma Form Strategic Partnership to Advance Novel Oncology Therapeutics
5个月前
Kelun-Biotech Achieves Breakthrough in First-Line NSCLC Treatment with World's First Successful ADC-Immunotherapy Combination
9个月前
Global Pharma Companies Seek R&D Efficiency Lessons from China's Clinical Trial Success
去年
Kelun-Biotech's SKB445 ADC Receives NMPA Approval for Advanced Solid Tumor Trials
去年
Kelun-Biotech's SKB535 Receives Approval for Clinical Trials in Advanced Solid Tumors
12个月前
Angelini Pharma Secures Exclusive Option for Sovargen's Novel Brain Health Asset SVG105
2个月前
NMPA Clears IND for HBM7575/SKB575, a Long-Acting TSLP Bispecific Antibody for Asthma
12个月前
Kinea Bio Secures $1.1M Investment and AAV-SLB101 License to Advance Dysferlinopathy Gene Therapy
去年
World's First HLA-G Targeted Exosome Therapy SOB100 Receives FDA Approval for Phase I Cancer Trials
去年
European Commission Approves Aflibercept Biosimilar OPUVIZ for Retinal Disorders
第 1 页,共 2 页
上一页
下一页